AI News

June 26, 2026

OpenAI & DeepMind

AI Research (general)

3D Spatial Pattern Matching

arXiv cs.AI · Jun 26

3D Spatial Pattern Matching

\chisao{}: A GPU-Native Parallel Optimizer for Multimodal Black-Box Functions via Convergence-Anticonvergence Oscillation

arXiv cs.LG (Machine Learning) · Jun 26

\chisao{}: A GPU-Native Parallel Optimizer for Multimodal Black-Box Functions via Convergence-Anticonvergence Oscillation

\textsc{DiARC}: Distinguishing Positive and Negative Samples Helps Improving ARC-like Reasoning Ability of Large Language Models

arXiv cs.AI · Jun 26

\textsc{DiARC}: Distinguishing Positive and Negative Samples Helps Improving ARC-like Reasoning Ability of Large Language Models

A Causal Foundation Model for Structure and Outcome Prediction

arXiv cs.LG (Machine Learning) · Jun 26

A Causal Foundation Model for Structure and Outcome Prediction

A Concept of Possibility for Real-World Events

arXiv cs.AI · Jun 26

A Concept of Possibility for Real-World Events

A Deterministic Control Plane for LLM Coding Agents

arXiv cs.AI · Jun 26

A Deterministic Control Plane for LLM Coding Agents

A General Framework for Learning Algebraic Properties from Cayley Graphs using Graph Neural Networks

arXiv cs.LG (Machine Learning) · Jun 26

A General Framework for Learning Algebraic Properties from Cayley Graphs using Graph Neural Networks

A Generalization Theory for JEPA-Based World Models

arXiv cs.LG (Machine Learning) · Jun 26

A Generalization Theory for JEPA-Based World Models

A Guideline-Aware AI Agent for Zero-Shot Target Volume Auto-Delineation

arXiv cs.AI · Jun 26

A Guideline-Aware AI Agent for Zero-Shot Target Volume Auto-Delineation

A Latent ODE Approach to Spatiotemporal Modeling of Cine Cardiac MRI

arXiv cs.AI · Jun 26

A Latent ODE Approach to Spatiotemporal Modeling of Cine Cardiac MRI

AI in Biotech & High-Impact Journals

Less Can Be More by Circulating Tumor DNA Use in ERBB2 -Positive Breast Cancer

JAMA Oncology (Online First) · Jun 25

Less Can Be More by Circulating Tumor DNA Use in ERBB2 -Positive Breast Cancer

Neoadjuvant Paclitaxel, Trastuzumab, and Pertuzumab for Stage II to III, ERBB2 -Positive Breast Cancer

JAMA Oncology (Online First) · Jun 25

Neoadjuvant Paclitaxel, Trastuzumab, and Pertuzumab for Stage II to III, ERBB2 -Positive Breast Cancer

Outcomes in Patients With Recurrent Ovarian Cancer and Exceptional Response to PARP Inhibitors

JAMA Oncology (Online First) · Jun 25

Outcomes in Patients With Recurrent Ovarian Cancer and Exceptional Response to PARP Inhibitors

Three-Body Problem at Digital Frontiers

JAMA Oncology (Online First) · Jun 25

Three-Body Problem at Digital Frontiers

Error in Open Access License

JAMA Oncology (Online First) · Jun 18

Error in Open Access License

One Ovary

JAMA Oncology (Online First) · Jun 18

One Ovary

Second Primary Malignant Neoplasms After T-Cell–Engaging Bispecific Antibody Therapy

JAMA Oncology (Online First) · Jun 18

Second Primary Malignant Neoplasms After T-Cell–Engaging Bispecific Antibody Therapy

Single-Fraction Stereotactic Body Radiotherapy for Localized Prostate Cancer

JAMA Oncology (Online First) · Jun 18

Single-Fraction Stereotactic Body Radiotherapy for Localized Prostate Cancer

Survival in the SONIA Trial

JAMA Oncology (Online First) · Jun 18

Survival in the SONIA Trial

Survival in the SONIA Trial

JAMA Oncology (Online First) · Jun 18

Survival in the SONIA Trial